Your session is about to expire
← Back to Search
Virtual Reality Therapy for Pain Management During Medical Procedures
N/A
Recruiting
Led By Navid Alem, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will investigate whether VRT can help manage pain and improve satisfaction for patients during a GNRFA procedure.
Who is the study for?
This trial is for adults over 18 who are undergoing a genicular nerve radiofrequency ablation, including those with past nerve blocks or similar procedures. It's not suitable for pregnant women, individuals with infections requiring isolation, blindness, deafness, severe motion sickness or nausea/vomiting, refusal to use VR headsets, need for sedation during the procedure, cognitive impairments like dementia or recent stroke/epilepsy/psychosis/claustrophobia.
What is being tested?
The study is testing 'Soothe VR', a virtual reality therapy during GNRFA procedures to see if it reduces pain and increases patient satisfaction compared to standard care without VR.
What are the potential side effects?
While Soothe VR itself may not have direct side effects like medications do; users might experience discomfort such as dizziness or nausea from using the headset especially if they're prone to motion sickness.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient Satisfaction with VR Device
Peak Pain During Procedure
Secondary study objectives
Additional Local Anesthetic
Pain Thoughts: Duration of Time Patient Spent Thinking of Pain
Patient Procedural Anxiety
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VR InterventionExperimental Treatment1 Intervention
The VR Intervention group will receive a genicular RFA with local anesthetic as per the standard-of-care and the use of the Soothe VR device.
Group II: ControlActive Control1 Intervention
The control group will receive a genicular RFA with local anesthetic as per the standard-of-care
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
566 Previous Clinical Trials
1,932,981 Total Patients Enrolled
4 Trials studying Pain
1,928 Patients Enrolled for Pain
Applied VRUNKNOWN
Navid Alem, MDPrincipal InvestigatorFaculty
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have recently undergone a procedure called genicular nerve radiofrequency ablation.You are unable to see or hear.You get car sick or feel nauseous/vomit frequently.It is okay to participate if you have had nerve blocks or radiofrequency ablation procedures in the past.You don't want to use the headset.You need to be asleep during the procedure.You have problems with memory or thinking abilities.You have a history of recent stroke, epilepsy, psychosis, or claustrophobia.
Research Study Groups:
This trial has the following groups:- Group 1: VR Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.